Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aptose Biosciences Inc.

    NASDAQ: APTO · Real-Time Price · USD
    1.71
    0.00 (0.00%)
    At close: Apr 01, 2025, 3:59 PM

    Aptose Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 474.55K 507.08K 616.53K
    Gross Profit
    		 n/a -474.55K -507.08K -616.53K
    Operating Income
    		 n/a -52.36M -42.6M -65.45M
    Interest Income
    		 357K 1.15M 788K 94K
    Pretax Income
    		 -25.43M -51.21M -41.82M -65.35M
    Net Income
    		 -25.43M -51.21M -41.82M -65.35M
    Selling & General & Admin
    		 11.15M 15.59M 14.51M 19.46M
    Research & Development
    		 15.1M 36.77M 28.09M 45.98M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 26.26M 52.36M 42.6M 65.45M
    Interest Expense
    		 -207K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 52.36M 42.6M 65.45M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 4.44M 6.75M 6.15M 5.94M
    Shares Outstanding (Diluted)
    		 1.34M 1.89M 1.89M 1.89M
    EPS (Basic)
    		 -5.73 -7.58 -6.8 -11.01
    EPS (Diluted)
    		 -18.94 -27.08 -22.12 -34.56
    EBITDA
    		 n/a -52.27M -42.48M -65.3M
    EBIT
    		 n/a -52.36M -42.6M -65.45M
    Depreciation & Amortization
    		 n/a 88K 120K 150K

    Add to Watchlist